Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Simon

Showing results (771-780 of 1,328) with videos related to

Pageof 133
Sort By:
Journal of Clinical Pharmacology|February 1, 1995
First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertensionW H Frishman, J F Burris, W J Mroczek, et al.
Open Forum Infectious Diseases|October 14, 2021
Impact of a Multiplex Polymerase Chain Reaction Panel on Duration of Empiric Antibiotic Therapy in Suspected Bacterial MeningitisJustin J Choi, Lars F Westblade, Lee S Gottesdiener, et al.
Clinical Cardiology|May 1, 1994
Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertensionM E Davidov, S P Singh, N D Vlachakis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2008
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxineMichael J Owens, Stan Krulewicz, Jeffrey S Simon, et al.
Osteoarthritis and Cartilage|May 9, 2015
OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hip osteoarthritisN E Lane, M C Hochberg, M C Nevitt, et al.
Journal of Postgraduate Medicine|April 1, 1980
A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiencyV N Bagadia, M T Gada, V K Mundra, et al.
Breast Cancer Research and Treatment|September 28, 2014
Mammography interval and breast cancer mortality in women over the age of 75Michael S Simon, Sylvia Wassertheil-Smoller, Cynthia A Thomson, et al.
American Journal of Infection Control|December 9, 2019
A comparison of the incidence of midline catheter-associated bloodstream infections to that of central line-associated bloodstream infections in 5 acute care hospitalsNancy J Hogle, Krystal M Balzer, Barbara G Ross, et al.
Arthritis and Rheumatism|September 29, 1998
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsL S Simon, F L Lanza, P E Lipsky, et al.
Life Science Alliance|September 18, 2021
An extended DNA-free intranuclear compartment organizes centrosome microtubules in malaria parasitesCaroline S Simon, Charlotta Funaya, Johanna Bauer, et al.
Pageof 133

Showing results (771-780 of 1,328) with videos related to

Sort By:
Pageof 133
Journal of Clinical Pharmacology|February 1, 1995
First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertensionW H Frishman, J F Burris, W J Mroczek, et al.
Open Forum Infectious Diseases|October 14, 2021
Impact of a Multiplex Polymerase Chain Reaction Panel on Duration of Empiric Antibiotic Therapy in Suspected Bacterial MeningitisJustin J Choi, Lars F Westblade, Lee S Gottesdiener, et al.
Clinical Cardiology|May 1, 1994
Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertensionM E Davidov, S P Singh, N D Vlachakis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2008
Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxineMichael J Owens, Stan Krulewicz, Jeffrey S Simon, et al.
Osteoarthritis and Cartilage|May 9, 2015
OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hip osteoarthritisN E Lane, M C Hochberg, M C Nevitt, et al.
Journal of Postgraduate Medicine|April 1, 1980
A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiencyV N Bagadia, M T Gada, V K Mundra, et al.
Breast Cancer Research and Treatment|September 28, 2014
Mammography interval and breast cancer mortality in women over the age of 75Michael S Simon, Sylvia Wassertheil-Smoller, Cynthia A Thomson, et al.
American Journal of Infection Control|December 9, 2019
A comparison of the incidence of midline catheter-associated bloodstream infections to that of central line-associated bloodstream infections in 5 acute care hospitalsNancy J Hogle, Krystal M Balzer, Barbara G Ross, et al.
Arthritis and Rheumatism|September 29, 1998
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsL S Simon, F L Lanza, P E Lipsky, et al.
Life Science Alliance|September 18, 2021
An extended DNA-free intranuclear compartment organizes centrosome microtubules in malaria parasitesCaroline S Simon, Charlotta Funaya, Johanna Bauer, et al.
Pageof 133